Appeal No. 2002-2279 Page 6 Application No. 08/556,667 If we understand the examiner’s position, it is that it would have been obvious for one skilled in the art to enrich a selected population of cells in a sample by capturing unwanted cells on particles coated with binding partners specific for the unwanted cells (as taught by Reynolds), allowing the particles to settle by gravity separation alone (as taught by Grenier, and also by Pry), and recovering cells of interest from the supernatant, because Grenier teaches that gravity separation “is useful where traditional purification or removal means are not appropriate, such as [ ] centrifugation or filtration” (Answer, page 4), and Reynolds teaches that the use of particles in a negative cell selection process “provides a high level of recovery” and “does not substantially physically damage the [cells of interest]” (Answer, pages 5-6). With respect to the requirement for “particles having a density of at least two times the density of the cells of interest” (claims 4 and 5, e.g.), the examiner appears to concede that none of the references teaches particles at least twice as dense as Reynold’s bone marrow cells, but argues that the “claims simply recite that the particles are at least two times [as] dense[ as] a cell[ ] where no particular type of cell is recited . . . [t]hus the particle can be twice as dense[ ] [as] some type of cells” (Answer, page 13). In any case, the examiner believes that “[t]he use of a known member of a class of materials, such as the particular size of a particle, in a process is not patentable if other members of the class were known to be useful for that purpose . . . [and n]o more than routine skill is involved in adjusting the density or size of component . . . to suit a particular starting material in order to achieve the results taught in the prior art” (id., pages 4-5). Nevertheless, we agree with appellants that none of the references relied on by the examiner describes or suggests particles “having a density at least two times thePage: Previous 1 2 3 4 5 6 7 8 9 10 NextLast modified: November 3, 2007